孟加拉国医药业

08218027
08319157
Bangladesh
War-torn economy Disrupted infrastructure Deficit in foreign currency All these, aggravated the overall healthcare situation of the country
• Pharmaceutical Industry has grown in Bangladesh in the last two decades at a considerable rate. Its healthy growth supports development of auxiliary industries for producing glass bottles, plastic containers, aluminum collapsible tubes, aluminum PP caps, infusion sets, disposable syringes, and corrugated cartons. Some of these products are also being exported. Printing and packaging industries and even the advertising agencies consider pharmaceutical industry as their major clients and a key driving force for their growth. • Pharmaceutical companies are either directly or indirectly contributing largely towards raising the standard of healthcare through enabling local healthcare personnel to gain access to newer products and also to latest drug information.
Bangladesh Pharmaceutical Industry
Today
Mainly dominated by local manufacturers
13% 87%
MNCs LocalFra bibliotekTop 10 pharmaceutical companies are local companies
Towards Self Sufficiency
1982: New Drug Policy
1982 Drug Policy largely encouraged local
production in pharmaceutical sector
As a result, a large number of local
companies invested in pharmaceutical manufacturing facilities
Bangladesh Pharmaceutical Industry
Today
One of the fastest growing business sectors Total Market Size in 2008: US $ 715 M Second highest contributor to national ex-chequer Largest white-collar labor intensive employment sector
ROLES OF PHARMACEUTICAL INDUSTRY IN BANGLADESH: • There are now 13 drug manufacturing units, which also manufacture certain basic materials. These include Paracetamol, Ampicillin Trihydrate, Amoxycillin Trihydrate, Diclofenac Sodium, Aluminium Hydroxide Dried Gel, Dextrose Monohydrate, Hard Gelatin capsule shell, Chloroquine Phosphate, Propranolol Hydrochloride, Benzoyl Metronidazole, Sodium Stibogluconate (Stibatin) and Pyrantel Pamoate. However, most of these are confined to the last stage of synthesis. There are three public sector drug manufacturing units. Two of them are the Dhaka and Bogra units of Essential Drug Company Ltd. (EDCL), which is functioning as a public limited company under the Ministry of Health and Family Welfare. EDCL produced medicines worth Tk 964 million in 2000.
97% Local Manufacturing Only 3% import Vaccine Anticancer Insulin
IMPORT
Singapore 75% Myanmar 90% Sri Lanka 85%
ROLES OF PHARMACEUTICAL INDUSTRY IN BANGLADESH:
PHARMACEUTICAL INDUSTRY FROM ECONOMIC PERSPECTIVE:
• The economy of Bangladesh is constituted by that of a developing country. Its per capita income in 2008 was US$1,500 significantly lower than India, Pakistan, both which are also lower than the world average of $10,497. By the International Monetary Fund, Bangladesh ranked as the 48th largest economy in the world in 2008.
arrangement) to potential LDCs and
Bangladesh Pharmaceutical Industry - Competitive Advantages
Taking advantages given by TRIPS Agreement
• Signed in 1995 & have been put in place since January 1, 2005 to protect in WTO states not only formulation of products but also the original molecules.
Bangladesh Pharmaceutical Industry - Competitive Advantages
Summary
Contract Manufacturing Huge investment in facility construction (US $250 m in last 3 years)
History of Pharmaceutical Industry of Bangladesh
In the post liberation period, health-care facilities were mostly dependent on Import Bangladesh Pharmaceutical sector remained as an `Import based’ sector during early 70’s
Bangladesh Pharmaceutical Industry - Competitive Advantages
Contract Manufacturing Opportunities
• Cost cutting measures by re-imbursement authorities in several observed • To capitalize on cost advantages, many major MNCs from developed countries are relocating Contract Manufacturing manufacturing (under developing countries Opportunity to expand business in developed markets developed countries
• Bangladesh and other LDCs are exempted from patent protection until 2016 • Bangladesh, among all 50 LDCs posses the strongest (and probably the only one) pharmaceutical manufacturing base.
Bangladesh Pharmaceutical Industry - Competitive Advantages
Compulsory Licensing:
Pharmaceutical companies in Bangladesh can play leading roles (capitalizing on a strong manufacturing base). In cases of national emergencies, companies from other countries may take long time to supply products under ‘Compulsory Licensing’, owing the lead time required for new product commercialization.
• Our presentation topic is Pharmaceutical Industry Sector Of Bangladesh
Submitted by
• Shakhawat Hossen (C) 08218010 • Naznin Akter • Naziur Rahman 08218048 • Liton Hossain • Abdul Baten Rafi 09120115 • Nowshad Amin
BANGLADESH
Taking advantages of TRIPS Agreement: Patented products for LDC
International GMP Certification Occurring
Cost advantages: World Generic Market
ROLES OF PHARMACEUTICAL INDUSTRY IN BANGLADESH: • The annual per capita drug consumption in Bangladesh is one of the lowest in the world. However, the industry has been a key contributor to the Bangladesh economy since independence. With the development of healthcare infrastructure and increase of health awareness and the purchasing capacity of people, this industry is expected to grow at a higher rate in future